Agent for treatment of Parkinson's disease

US4970200A · kind A · utility

Assignee

• SCHERING CORPORATION · US

Inventors

• Walther Birkmayer · Wien, AT
• Jorg Birkmayer · Wien, AT
• Reinhard Horowski
• Helmut Wachtel · Berlin, DE
• Peter-Andreas Loschmann · Berlin, DE

Key dates

• Filing date: Mar 1, 1989
• Grant date: Nov 13, 1990
• Expiry date: Mar 1, 2009

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07H19/207
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The enzyme cofactor nicotinamide adenine dinucleotide or a salt thereof is useful for the treatment of Parkinson's disease.